Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2012, Article ID 931902, 12 pages
Clinical Study

Bilateral Transplantation of Allogenic Adult Human Bone Marrow-Derived Mesenchymal Stem Cells into the Subventricular Zone of Parkinson’s Disease: A Pilot Clinical Study

1Advanced Neuro Science Institute, BGS Global Hospital, Bangalore 560060, India
2ANSA Research Foundation, Indiranagar, Bangalore 560038, India

Received 31 August 2011; Accepted 1 November 2011

Academic Editor: Francesco Dazzi

Copyright © 2012 N. K. Venkataramana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Suppl Figure 1: Illustrates the trilneage differentiation of BM-MSCs into A. adipocytes stained using Oil Red O, B. osteoblasts stained with Von Kossa and C. chondrocytes stained with Safranin O using standard inducing agents. The panel on the left hand side shows the negative control of BM-MSCs stained, respectively.

Suppl Figure 2: Represents the karyotype of a healthy normal male bone marrow donor mesenchymal stem cells used for allogenic transplantation in PD patients this study. (Supplementary data).

Suppl Figure 3: MR tractography: (a) average ± SD of Levels of fractional anisotropic values (FA) in 12 different sites in brain of PD patients.

  1. Supplementary Material